Biosplice Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 123
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 10

Biosplice Therapeutics General Information

Description

Operator of tissue-level therapeutic drugs company intended to cure degenerative diseases in patients. The company discovers new targets and biological processes in the Wnt pathway, allowing them to develop small molecule drugs that potentially address numerous degenerative conditions as well as many forms of cancer.

Contact Information

Website
www.biosplice.com
Formerly Known As
Wintherix & Epitherix, Samumed
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 9360 Towne Centre Drive
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Biosplice Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosplice Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biosplice Therapeutics‘s full profile, request access.

Request a free trial

Biosplice Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of tissue-level therapeutic drugs company intended to cure degenerative diseases in patients. The company disco
Drug Discovery
San Diego, CA
123 As of 2022
00000
0000000 0000 00000

00000 00

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000 000000000
Pasadena, CA
0 As of 0000
00.000
00000000 00.000

0000

ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
0000000000000
San Diego, CA
00 As of 0000
00.000
0.00 0000-00-00
0000000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosplice Therapeutics Competitors (49)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lixte Biotechnology Holdings Corporation Pasadena, CA 0 00.000 00000000 00.000
0000 Venture Capital-Backed San Diego, CA 00 00.000 0000000000 0
000000000 00000000 Venture Capital-Backed Kalamazoo, MI 00 0000 0000000000 0 0000
00000000 000000000 Accelerator/Incubator Backed New York, NY 000000000000
000000 00000000000 Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
You’re viewing 5 of 49 competitors. Get the full list »

Biosplice Therapeutics Patents

  • 312

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 43

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Biosplice Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3911317-A2 Methods of treating cartilage disorders through inhibition of clk and dyrk Pending 17-Jan-2019 00000000000
US-10759799-B2 Indazole containing macrocycles and therapeutic uses thereof Active 15-Jun-2018 0000000000 0
US-20190382402-A1 Indazole containing macrocycles and therapeutic uses thereof Granted 15-Jun-2018 0000000000
AU-2019224075-A1 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof Pending 23-Feb-2018 0000000000
US-20190263821-A1 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof Granted 23-Feb-2018 C07D487/04 0
To view Biosplice Therapeutics’s complete patent history, request access »

Biosplice Therapeutics Executive Team (16)

Name Title Board Seat Contact Info
Cevdet Samikoglu Chief Executive Officer & Board Member
Erich Horsley Chief Financial Officer & Chief Business Officer
Philippe Marchand Ph.D Chief Operating Officer
Scott Bulcao Chief Legal Officer
Osman Kibar Ph.D Co-Founder & Executive Chairman
You’re viewing 5 of 16 executive team members. Get the full list »

Biosplice Therapeutics Board Members (9)

Name Representing Role Since
000000 000000000 Biosplice Therapeutics Chief Executive Officer & Board Member 000 0000
00000000 0000000 SymBiosis Capital Management Board Observer 000 0000
00000 0000000 Self Board Member 000 0000
000 00000000 00 aMoon Fund Board Member 000 0000
000 00000 00.0 Eventide Asset Management Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Biosplice Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosplice Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biosplice Therapeutics‘s full profile, request access.

Request a free trial